Related Experiment Video
Updated: May 8, 2026
Biofunctionalized Prussian Blue Nanoparticles for Multimodal Molecular Imaging Applications
Published on: April 28, 2015
Ytterbium Doping-Retooled Prussian Blue for Tumor Metabolism Interference Therapy
Junlie Yao1,2, Jie Xing1, Yuxin Yao1,3
1Laboratory of Advanced Theranostic Materials and Technology, Ningbo Key Laboratory of Biomedical Imaging Probe Materials and Technology, Zhejiang International Cooperation Base of Biomedical Materials Technology and Application, Ningbo Cixi Institute of Biomedical Engineering, Ningbo Institute of Materials Technology and Engineering, Chinese Academy of Sciences, Ningbo 315201, China.
This study repurposed Prussian blue nanoparticles by doping with ytterbium (Yb) to enhance anticancer efficacy. Ytterbium-doped Prussian blue nanoparticles show promise as a new drug candidate for cancer therapy.
Area of Science:
- Nanotechnology
- Materials Science
- Drug Discovery
Background:
- Drug repurposing accelerates clinical evaluation of existing drugs.
- Prussian blue (PB) shows potential but faces limitations in nanodrug formulation and efficacy.
- Lanthanide ions offer diagnostic and therapeutic advantages for biomedical applications.
Purpose of the Study:
- To synthesize Ytterbium (Yb)-doped Prussian blue nanoparticles (NPs) for improved anticancer efficacy.
- To explore the potential of Yb-doped PB NPs as a repurposed antineoplastic drug.
- To investigate the underlying anticancer mechanisms of these novel nanoparticles.
Main Methods:
- One-step synthesis of interstitial Yb-doped PB NPs.
- Systematic comparative analysis of NP properties (morphology, size, composition, crystal structure).
- Evaluation of anticancer mechanisms involving mammalian target of rapamycin (mTOR) and adenosine monophosphate-activated protein kinase (AMPK) pathways.
Main Results:
- Yb-enriched PB NPs demonstrated improved characteristics for therapeutic applications.
- Yb-doped PB NPs were identified as a promising antineoplastic drug candidate.
- The nanoparticles were shown to disrupt cellular anabolism, catabolism, and homeostasis via mTOR and AMPK pathways.
Conclusions:
- This work successfully implements drug repurposing for Prussian blue.
- Yb-doped PB NPs represent a foundation for next-generation theranostic nanodrugs.
- The findings expand the biological applications of Yb ions in nanomedicine.
